Data / Form D filings / Nirrin Technologies, Inc.
Nirrin Technologies, Inc.: Form D filings
Nirrin Technologies, Inc., a biotechnology company in Billerica, MA, filed 3 Form D notices with the SEC between 2021 and 2026. The latest, on June 15, 2026, reports $6.7 million sold of a $9.7 million offering to 23 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 44 MANNING RD., Billerica, MA, 01821
- Phone
- (508) 404-8329
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1889145
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | New notice | $9,711,196 | $6,699,781 | $3,011,415 | 23 | Sep 23, 2025 | sec.gov |
| Feb 14, 2024 | New notice | $6,000,000 | $4,818,026 | $1,181,974 | 20 | Feb 1, 2024 | sec.gov |
| Oct 20, 2021 | New notice | $8,500,000 | $8,500,000 | 1 | Oct 6, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David Seldin | Director | |
| Matthew Gunnison | Director | |
| David Michael | Director | |
| Bryan Hassell | Executive Officer |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Jun 15, 2026 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Nirrin Technologies, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.